Published in Microvasc Res on November 07, 2008
Induction of cellular antioxidant defense by amifostine improves ventilator-induced lung injury. Crit Care Med (2011) 2.24
The multifaceted functions of neutrophils. Annu Rev Pathol (2013) 1.97
Opening the flood-gates: how neutrophil-endothelial interactions regulate permeability. Trends Immunol (2009) 1.82
Intermittent hypoxia-induced endothelial barrier dysfunction requires ROS-dependent MAP kinase activation. Am J Physiol Cell Physiol (2014) 1.46
Myosin light chain kinase in microvascular endothelial barrier function. Cardiovasc Res (2010) 1.37
Inactivation of renal mitochondrial respiratory complexes and manganese superoxide dismutase during sepsis: mitochondria-targeted antioxidant mitigates injury. Am J Physiol Renal Physiol (2014) 1.25
Role of reactive oxygen and nitrogen species in the vascular responses to inflammation. Free Radic Biol Med (2011) 1.17
Catalase and superoxide dismutase conjugated with platelet-endothelial cell adhesion molecule antibody distinctly alleviate abnormal endothelial permeability caused by exogenous reactive oxygen species and vascular endothelial growth factor. J Pharmacol Exp Ther (2011) 1.07
Nitric oxide synthase 3 contributes to ventilator-induced lung injury. Am J Physiol Lung Cell Mol Physiol (2010) 1.04
Neuro-oxidative-nitrosative stress in sepsis. J Cereb Blood Flow Metab (2011) 1.01
Myosin light chain kinase signaling in endothelial barrier dysfunction. Med Res Rev (2012) 0.98
Overexpression of stanniocalcin-1 inhibits reactive oxygen species and renal ischemia/reperfusion injury in mice. Kidney Int (2012) 0.97
Neutrophil transmigration, focal adhesion kinase and endothelial barrier function. Microvasc Res (2011) 0.94
Blood cells and endothelial barrier function. Tissue Barriers (2015) 0.94
Pharmacological targets in the renal peritubular microenvironment: implications for therapy for sepsis-induced acute kidney injury. Pharmacol Ther (2012) 0.93
Erythropoetin as a novel agent with pleiotropic effects against acute lung injury. Eur J Clin Pharmacol (2010) 0.87
Resistin increases monolayer permeability of human coronary artery endothelial cells. PLoS One (2013) 0.87
Targeted interception of signaling reactive oxygen species in the vascular endothelium. Ther Deliv (2012) 0.87
Persistent neutrophil dysfunction and suppression of acute lung injury in mice following cecal ligation and puncture sepsis. J Innate Immun (2014) 0.84
Endothelial targeting of nanocarriers loaded with antioxidant enzymes for protection against vascular oxidative stress and inflammation. Biomaterials (2014) 0.83
Redox regulation of endothelial canonical transient receptor potential channels. Antioxid Redox Signal (2011) 0.82
Nanoparticles, lung injury, and the role of oxidant stress. Annu Rev Physiol (2013) 0.82
The role of repeatedly heated soybean oil in the development of hypertension in rats: association with vascular inflammation. Int J Exp Pathol (2012) 0.82
Pro-inflammatory endothelial cell dysfunction is associated with intersectin-1s down-regulation. Respir Res (2011) 0.81
Loss of caveolin-1 and adiponectin induces severe inflammatory lung injury following LPS challenge through excessive oxidative/nitrative stress. Am J Physiol Lung Cell Mol Physiol (2014) 0.80
Lipoteichoic acid from Staphylococcus aureus induces lung endothelial cell barrier dysfunction: role of reactive oxygen and nitrogen species. PLoS One (2012) 0.80
Selenium-dependent regulation of oxidative stress and immunity in periparturient dairy cattle. Vet Med Int (2013) 0.80
12/15-Lipoxygenase-dependent ROS production is required for diet-induced endothelial barrier dysfunction. J Lipid Res (2015) 0.80
White blood cell counts and neutrophil to lymphocyte ratio in the diagnosis of testicular cancer: a simple secondary serum tumor marker. Int Braz J Urol (2016) 0.80
Systems biology of HBOC-induced vasoconstriction. Curr Drug Discov Technol (2012) 0.79
Mathematical and computational models of oxidative and nitrosative stress. Crit Rev Biomed Eng (2011) 0.79
Intranasal curcumin ameliorates lipopolysaccharide-induced acute lung injury in mice. Inflammation (2015) 0.78
Anti-inflammatory effects of tobramycin and a copper-tobramycin complex with superoxide dismutase-like activity. Br J Pharmacol (2013) 0.78
Caveolin-1 regulates the expression of tight junction proteins during hyperoxia-induced pulmonary epithelial barrier breakdown. Respir Res (2016) 0.77
Macrophages mediate colon carcinoma cell adhesion in the rat liver after exposure to lipopolysaccharide. Oncoimmunology (2012) 0.76
Reactive oxygen species adversely impacts bone marrow microenvironment in diabetes. Antioxid Redox Signal (2014) 0.76
Chronic ingestion of alcohol modulates expression of ubiquitin editing enzyme A20 in lung macrophages. Multidiscip Respir Med (2011) 0.76
The redox mechanism for vascular barrier dysfunction associated with metabolic disorders: Glutathionylation of Rac1 in endothelial cells. Redox Biol (2016) 0.76
Interaction of endothelial cells with macrophages-linking molecular and metabolic signaling. Pflugers Arch (2017) 0.76
Oxidative Stress and Nuclear Factor κB (NF-κB) Increase Peritoneal Filtration and Contribute to Ascites Formation in Nephrotic Syndrome. J Biol Chem (2016) 0.75
Renal Mitochondrial Lipid Peroxidation during Sepsis. J Kidney (2016) 0.75
Caveolin-1 regulates Rac1 activation and rat pulmonary microvascular endothelial hyperpermeability induced by TNF-α. PLoS One (2013) 0.75
Csk-Induced Phosphorylation of Src at Tyrosine 530 is Essential for H2O2-Mediated Suppression of ERK1/2 in Human Umbilical Vein Endothelial Cells. Sci Rep (2015) 0.75
Neutrophil-mediated vascular barrier injury: Role of neutrophil extracellular traps. Microcirculation (2017) 0.75
Blood Brothers: Hemodynamics and Cell-Matrix Interactions in Endothelial Function. Antioxid Redox Signal (2016) 0.75
Hemin Causes Lung Microvascular Endothelial Barrier Dysfunction by Necroptotic Cell Death. Am J Respir Cell Mol Biol (2017) 0.75
Accuracy of Doppler echocardiography in the hemodynamic assessment of pulmonary hypertension. Am J Respir Crit Care Med (2009) 3.96
Tricuspid annular displacement predicts survival in pulmonary hypertension. Am J Respir Crit Care Med (2006) 3.59
Protective effects of sphingosine 1-phosphate in murine endotoxin-induced inflammatory lung injury. Am J Respir Crit Care Med (2004) 3.59
Endothelial dysfunction in pulmonary hypertension. Circulation (2004) 2.82
Sphingosine 1-phosphate reduces vascular leak in murine and canine models of acute lung injury. Am J Respir Crit Care Med (2004) 2.73
Imatinib mesylate as add-on therapy for pulmonary arterial hypertension: results of the randomized IMPRES study. Circulation (2013) 2.64
Tricuspid annular plane systolic excursion is a robust outcome measure in systemic sclerosis-associated pulmonary arterial hypertension. J Rheumatol (2011) 2.48
Characterization of connective tissue disease-associated pulmonary arterial hypertension from REVEAL: identifying systemic sclerosis as a unique phenotype. Chest (2010) 2.35
Comprehensive invasive and noninvasive approach to the right ventricle-pulmonary circulation unit: state of the art and clinical and research implications. Circulation (2009) 2.17
Clinical differences between idiopathic and scleroderma-related pulmonary hypertension. Arthritis Rheum (2006) 2.04
Perspectives on oral pulmonary hypertension therapies recently approved by the U.S. Food and Drug Administration. Ann Am Thorac Soc (2015) 2.02
Pulmonary capillary wedge pressure augments right ventricular pulsatile loading. Circulation (2011) 1.92
Randomized clinical trial of aspirin and simvastatin for pulmonary arterial hypertension: ASA-STAT. Circulation (2011) 1.91
Use of consomic rats for genomic insights into ventilator-associated lung injury. Am J Physiol Lung Cell Mol Physiol (2007) 1.86
Diagnosis, assessment, and treatment of non-pulmonary arterial hypertension pulmonary hypertension. J Am Coll Cardiol (2009) 1.78
PDE5A inhibitor treatment of persistent pulmonary hypertension after mechanical circulatory support. Circ Heart Fail (2008) 1.75
Epidermal growth factor receptor (EGFR) regulates mechanical ventilation-induced lung injury in mice. Transl Res (2008) 1.57
Treatment of sarcoidosis-associated pulmonary hypertension. A two-center experience. Chest (2008) 1.57
Modulation of inducible nitric oxide synthase by hypoxia in pulmonary artery endothelial cells. Am J Respir Cell Mol Biol (2002) 1.55
Disruption of Nrf2 impairs the resolution of hyperoxia-induced acute lung injury and inflammation in mice. J Immunol (2009) 1.53
Hemodynamic predictors of survival in scleroderma-related pulmonary arterial hypertension. Am J Respir Crit Care Med (2010) 1.44
Mechanical stress activates xanthine oxidoreductase through MAP kinase-dependent pathways. Am J Physiol Lung Cell Mol Physiol (2006) 1.42
Genetic and pharmacologic evidence links oxidative stress to ventilator-induced lung injury in mice. Am J Respir Crit Care Med (2007) 1.41
Survival in pulmonary hypertension associated with the scleroderma spectrum of diseases: impact of interstitial lung disease. Arthritis Rheum (2009) 1.40
Cytoskeletal changes in hypoxic pulmonary endothelial cells are dependent on MAPK-activated protein kinase MK2. J Biol Chem (2002) 1.40
Hyponatremia predicts right heart failure and poor survival in pulmonary arterial hypertension. Am J Respir Crit Care Med (2008) 1.38
Inducible nitric oxide synthase contributes to ventilator-induced lung injury. Am J Respir Crit Care Med (2005) 1.35
Attenuation of chronic hypoxic pulmonary hypertension by simvastatin. Am J Physiol Heart Circ Physiol (2003) 1.34
Schistosomiasis-induced experimental pulmonary hypertension: role of interleukin-13 signaling. Am J Pathol (2010) 1.33
Regression of chronic hypoxic pulmonary hypertension by simvastatin. Am J Physiol Lung Cell Mol Physiol (2007) 1.30
Identification of candidate genes in scleroderma-related pulmonary arterial hypertension. Transl Res (2008) 1.27
Activation of the STAT pathway in acute lung injury. Am J Physiol Lung Cell Mol Physiol (2004) 1.25
Mitogen activated protein kinase activated protein kinase 2 regulates actin polymerization and vascular leak in ventilator associated lung injury. PLoS One (2009) 1.24
Right ventricular dysfunction in systemic sclerosis-associated pulmonary arterial hypertension. Circ Heart Fail (2013) 1.21
Soluble guanylyl cyclase contributes to ventilator-induced lung injury in mice. Am J Physiol Lung Cell Mol Physiol (2008) 1.18
Hypoxia alters biophysical properties of endothelial cells via p38 MAPK- and Rho kinase-dependent pathways. Am J Physiol Cell Physiol (2005) 1.18
Myocardial delayed enhancement in pulmonary hypertension: pulmonary hemodynamics, right ventricular function, and remodeling. AJR Am J Roentgenol (2011) 1.15
Resistin-like molecule-beta in scleroderma-associated pulmonary hypertension. Am J Respir Cell Mol Biol (2009) 1.12
Redox imbalance and ventilator-induced lung injury. Antioxid Redox Signal (2007) 1.10
Long-term outcome of bosentan treatment in idiopathic pulmonary arterial hypertension and pulmonary arterial hypertension associated with the scleroderma spectrum of diseases. J Heart Lung Transplant (2005) 1.09
Innate immunity against bacterial infection following hyperoxia exposure is impaired in NRF2-deficient mice. J Immunol (2009) 1.09
Activated protein C protects against ventilator-induced pulmonary capillary leak. Am J Physiol Lung Cell Mol Physiol (2009) 1.09
Strategic plan for lung vascular research: An NHLBI-ORDR Workshop Report. Am J Respir Crit Care Med (2010) 1.09
Vascular receptor autoantibodies in pulmonary arterial hypertension. Am J Respir Crit Care Med (2015) 1.08
Alveolar cell apoptosis is dependent on p38 MAP kinase-mediated activation of xanthine oxidoreductase in ventilator-induced lung injury. J Appl Physiol (1985) (2008) 1.08
Trials and Tribulations of Therapies for the Acute Respiratory Distress Syndrome. Crit Care Med (2016) 1.07
Protective role of PI3-kinase/Akt/eNOS signaling in mechanical stress through inhibition of p38 mitogen-activated protein kinase in mouse lung. Acta Pharmacol Sin (2010) 1.06
The triterpenoid CDDO-imidazolide confers potent protection against hyperoxic acute lung injury in mice. Am J Respir Crit Care Med (2009) 1.05
One hundred years of research in the pathogenesis of pulmonary hypertension. Am J Respir Cell Mol Biol (2005) 1.05
Immune and inflammatory mechanisms in pulmonary arterial hypertension. Prog Cardiovasc Dis (2012) 1.03
Systemic sclerosis-associated pulmonary arterial hypertension. Am J Respir Crit Care Med (2010) 1.03
EGFR-activated signaling and actin remodeling regulate cyclic stretch-induced NRF2-ARE activation. Am J Respir Cell Mol Biol (2006) 1.02
Xanthine oxidoreductase in respiratory and cardiovascular disorders. Am J Physiol Lung Cell Mol Physiol (2008) 1.02
An official American Thoracic Society Statement: pulmonary hypertension phenotypes. Am J Respir Crit Care Med (2014) 1.02
Portopulmonary hypertension: a tale of two circulations. Chest (2003) 1.00
p53 mediates cigarette smoke-induced apoptosis of pulmonary endothelial cells: inhibitory effects of macrophage migration inhibitor factor. Am J Respir Cell Mol Biol (2010) 1.00
Systemic sclerosis-associated pulmonary arterial hypertension. Chest (2013) 1.00
Right and left ventricular myocardial perfusion reserves correlate with right ventricular function and pulmonary hemodynamics in patients with pulmonary arterial hypertension. Radiology (2010) 0.99
Pulmonary artery measurements in pulmonary hypertension: the role of computed tomography. J Thorac Imaging (2013) 0.98
Resolution of experimental lung injury by monocyte-derived inducible nitric oxide synthase. J Immunol (2012) 0.97
Outcomes of noncardiac, nonobstetric surgery in patients with PAH: an international prospective survey. Eur Respir J (2012) 0.96
A critical role for the protein apoptosis repressor with caspase recruitment domain in hypoxia-induced pulmonary hypertension. Circulation (2011) 0.96
Unique predictors of mortality in patients with pulmonary arterial hypertension associated with systemic sclerosis in the REVEAL registry. Chest (2014) 0.96
Pulmonary arterial hypertension associated with systemic sclerosis. Expert Rev Respir Med (2011) 0.95
Pulmonary arterial hypertension: MR imaging-derived first-pass bolus kinetic parameters are biomarkers for pulmonary hemodynamics, cardiac function, and ventricular remodeling. Radiology (2012) 0.95
Scleroderma lung disease. Clin Rev Allergy Immunol (2011) 0.93
Cardiac complications of systemic sclerosis: recent progress in diagnosis. Curr Opin Rheumatol (2010) 0.92
Disseminated herpes simplex virus and varicella zoster virus coinfection in a patient taking thalidomide for relapsed multiple myeloma. J Clin Microbiol (2002) 0.92
Serum endostatin is a genetically determined predictor of survival in pulmonary arterial hypertension. Am J Respir Crit Care Med (2015) 0.91
Systemic sclerosis-related pulmonary hypertension associated with interstitial lung disease: impact of pulmonary arterial hypertension therapies. Arthritis Rheum (2011) 0.91
Regional and global biventricular function in pulmonary arterial hypertension: a cardiac MR imaging study. Radiology (2012) 0.91
Pulmonary hypertension as a risk factor for death in patients with sickle cell disease. N Engl J Med (2004) 0.90
Increased right ventricular Septomarginal trabeculation mass is a novel marker for pulmonary hypertension: comparison with ventricular mass index and right ventricular mass. Invest Radiol (2011) 0.90
Upregulation of xanthine oxidase by tobacco smoke condensate in pulmonary endothelial cells. Toxicol Appl Pharmacol (2003) 0.89
Differential gene expression in chronic hypoxic pulmonary hypertension: effect of simvastatin treatment. Chest (2005) 0.87
Mitogen-activated protein kinase-activated protein kinase 2 mediates apoptosis during lung vascular permeability by regulating movement of cleaved caspase 3. Am J Respir Cell Mol Biol (2014) 0.87
Pulmonary endothelial cell NOX. Am J Respir Cell Mol Biol (2012) 0.87
Pulmonary arterial hypertension in connective tissue diseases. Heart Fail Clin (2012) 0.86
Erythroid-specific transcriptional changes in PBMCs from pulmonary hypertension patients. PLoS One (2012) 0.85
Xanthine oxidoreductase is a critical mediator of cigarette smoke-induced endothelial cell DNA damage and apoptosis. Free Radic Biol Med (2013) 0.85
Macrophage migration inhibitory factor is a novel determinant of cigarette smoke-induced lung damage. Am J Respir Cell Mol Biol (2014) 0.85
Estrogen modulates xanthine dehydrogenase/xanthine oxidase activity by a receptor-independent mechanism. Antioxid Redox Signal (2003) 0.82
Right ventricular dysfunction in chronic lung disease. Cardiol Clin (2012) 0.82
Therapy for pulmonary arterial hypertension associated with systemic sclerosis. Curr Opin Rheumatol (2009) 0.80
Right ventricle dysfunction in pulmonary hypertension: mechanisms and modes of detection. Curr Opin Pulm Med (2015) 0.79
Real-time single-heartbeat fast strain-encoded imaging of right ventricular regional function: normal versus chronic pulmonary hypertension. Magn Reson Med (2010) 0.79
Interleukin-6 and tumor necrosis factor-α are associated with quality of life-related symptoms in pulmonary arterial hypertension. Ann Am Thorac Soc (2015) 0.79
N-terminal brain natriuretic peptide in scleroderma-associated pulmonary arterial hypertension. Eur Heart J (2006) 0.78
Severity of systemic sclerosis-associated pulmonary arterial hypertension in African Americans. Medicine (Baltimore) (2014) 0.78
Severe respiratory muscle weakness related to long-term colchicine therapy. Respir Care (2004) 0.77
Is pulmonary arterial hypertension really a late complication of systemic sclerosis? Chest (2010) 0.77
Drumming up prognostic significance in a heartbeat in pulmonary arterial hypertension. Am J Respir Crit Care Med (2012) 0.77
Pulmonary hypertension due to lung disease and/or hypoxia. Clin Chest Med (2013) 0.77
Linking new and old concepts: inflammation meets the Warburg phenomenon in pulmonary arterial hypertension. J Mol Med (Berl) (2011) 0.76
Inflammatory mechanisms in the pathogenesis of pulmonary arterial hypertension. Compr Physiol (2011) 0.75
Pulmonary Arterial Compliance in Acute Respiratory Distress Syndrome: Clinical Determinants and Association With Outcome From the Fluid and Catheter Treatment Trial Cohort. Crit Care Med (2016) 0.75
Moving beyond the "Allegory of the Cave" in the assessment of pulmonary arterial hypertension. J Appl Physiol (1985) (2011) 0.75
Prediction of pulmonary artery pressure. Chest (2005) 0.75
Survival in systemic sclerosis-related pulmonary arterial hypertension in the modern treatment era. Am J Respir Crit Care Med (2009) 0.75
Drs. Mathai and Hassoun reply. J Rheumatol (2013) 0.75